Drug delivery has progressed over the last six decades until becoming an essential part of pharmaceutical sciences.
From the first active delivery approved for clinical use, the technology has brought remarkable developments with significant clinical implications. In many fields of life science, topical routes have been increasingly used as alternatives to oral routes favouring the transference of technologies to cosmetics. In that sense, delivery systems in cosmetics are growing rapidly.
Up to 25 parameters are considered by our researchers when developing an active delivery system such as: size, payload, depth, targeting, booster action, level of use, bioavailability, simplicity, versatility, easy-customization or patentability.
